Andres J. M. Ferreri

Quick facts

Phase 2 pipeline

• BEAM conditioning
• clarithromycin, oral, high dose
• Induction Phase
• Intensification phase
• intralesional rituximab
• supplemental autologous serum

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Andres J. M. Ferreri portfolio CI brief
• Andres J. M. Ferreri pipeline updates RSS